de Prost, Nicolas http://orcid.org/0000-0002-4833-4320
Audureau, Etienne
Heming, Nicholas
Gault, Elyanne
Pham, Tài http://orcid.org/0000-0002-4373-0711
Chaghouri, Amal
de Montmollin, Nina
Voiriot, Guillaume
Morand-Joubert, Laurence
Joseph, Adrien
Chaix, Marie-Laure
Préau, Sébastien http://orcid.org/0000-0002-8638-7183
Favory, Raphaël
Guigon, Aurélie
Luyt, Charles-Edouard
Burrel, Sonia http://orcid.org/0000-0002-7783-2601
Mayaux, Julien
Marot, Stéphane
Roux, Damien
Descamps, Diane
Meireles, Sylvie
Pène, Frédéric
Rozenberg, Flore
Contou, Damien
Henry, Amandine http://orcid.org/0000-0002-8935-8185
Gaudry, Stéphane
Brichler, Ségolène
Timsit, Jean-François
Kimmoun, Antoine
Hartard, Cédric
Jandeaux, Louise-Marie
Fafi-Kremer, Samira http://orcid.org/0000-0003-3886-7833
Gabarre, Paul
Emery, Malo
Garcia-Sanchez, Claudio
Jochmans, Sébastien
Pitsch, Aurélia
Annane, Djillali
Azoulay, Elie
Mekontso Dessap, Armand
Rodriguez, Christophe http://orcid.org/0000-0002-9817-5006
Pawlotsky, Jean-Michel http://orcid.org/0000-0003-0745-7559
Fourati, Slim
Funding for this research was provided by:
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS 0153, ANRS 0153)
Article History
Received: 14 July 2022
Accepted: 29 September 2022
First Online: 12 October 2022
Change Date: 7 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-022-34575-0
Competing interests
: S.F. has served as a speaker for GlaxoSmithKline, Abbvie, and Abbott Diagnostics. J.-M.P. has served as an advisor or speaker for Abbvie, Arbutus, Assembly Biosciences, Gilead and Merck. E.A. has received fees for lectures from Alexion, Sanofi, Gilead and Pfizer. His hospital has received research grant from Pfizer, MSD and Alexion. D.D. served as an advisor for Gilead-Sciences, ViiV Health care, Janssen-Cilag et MSD. F.P. served as an advisor for Gilead; he also received research grant from Alexion. C.-E.L. received lecture fees from MSD, Aerogen, Advanzpharma, and BioMérieux, outside the submitted work. J.-F.T. served as an advisor for pfizer, Gilead, BD, Gilead, Merck; he also received research grant from Thermofischer, merck, Pfizer, Biomerieux; lectures: pfizer, biomerieux BD, Merck, Shionoghi outside the submitted work. Other authors have no conflict of interest to disclose.